President Trump nominated Dr. Heidi Overton, deputy director of the White House Domestic Policy Council and a physician with prior work at the America First Policy Institute, as FDA commissioner on August 18-19, 2026, shortly after former commissioner Marty Makary’s May resignation left Kyle Diamantas as acting head. The Senate confirmation process, led by the HELP Committee under Sen. Bill Cassidy, represents the central hurdle. Cassidy has publicly voiced strong reservations over Overton’s involvement in a recent childhood vaccine schedule executive order and her limited senior managerial experience at the agency level. Administration allies, including HHS Secretary Robert F. Kennedy Jr., have endorsed her alignment with administration health priorities. No hearing dates have been set, and committee or floor timelines remain fluid amid a narrowly Republican-controlled Senate.
Експериментальне резюме, згенероване ШІ з посиланням на дані Polymarket. Це не торгова порада і не впливає на вирішення цього ринку. · ОновленоSeptember 30
34%
October 31
52%
November 30
51%
December 31
52%
$553 Обс.
September 30
34%
October 31
52%
November 30
51%
December 31
52%
If Heidi Overton's nomination is formally withdrawn, or if the Senate rejects the nomination, this market will immediately resolve to “No”.
The Senate must confirm this nominee as Commissioner of the U.S. Food and Drug Administration for this market to resolve to "Yes". Recess appointments without Senate confirmation will not count toward a "Yes" resolution.
The primary resolution source for this market is official information from the U.S. Senate; however, a consensus of credible reporting may also be used.
Ринок відкрито: Aug 20, 2026, 5:43 PM ET
Resolver
0x65070BE91...If Heidi Overton's nomination is formally withdrawn, or if the Senate rejects the nomination, this market will immediately resolve to “No”.
The Senate must confirm this nominee as Commissioner of the U.S. Food and Drug Administration for this market to resolve to "Yes". Recess appointments without Senate confirmation will not count toward a "Yes" resolution.
The primary resolution source for this market is official information from the U.S. Senate; however, a consensus of credible reporting may also be used.
Resolver
0x65070BE91...President Trump nominated Dr. Heidi Overton, deputy director of the White House Domestic Policy Council and a physician with prior work at the America First Policy Institute, as FDA commissioner on August 18-19, 2026, shortly after former commissioner Marty Makary’s May resignation left Kyle Diamantas as acting head. The Senate confirmation process, led by the HELP Committee under Sen. Bill Cassidy, represents the central hurdle. Cassidy has publicly voiced strong reservations over Overton’s involvement in a recent childhood vaccine schedule executive order and her limited senior managerial experience at the agency level. Administration allies, including HHS Secretary Robert F. Kennedy Jr., have endorsed her alignment with administration health priorities. No hearing dates have been set, and committee or floor timelines remain fluid amid a narrowly Republican-controlled Senate.
Експериментальне резюме, згенероване ШІ з посиланням на дані Polymarket. Це не торгова порада і не впливає на вирішення цього ринку. · Оновлено



Обережно з зовнішніми посиланнями.
Обережно з зовнішніми посиланнями.
Часті запитання